Sudeep Pharma Limited · NSE: SUDEEPPHRM · BSE: 544619
Sudeep Pharma
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 04 Aug 2026.
Q1 FY27 · Consolidated
Revenue
158.27₹ Cr
— vs year ago
Net profit
40.59₹ Cr
— vs year ago
EPS, basic
3.59₹
— vs year ago
Net margin
25.6%
— vs year ago
Revenue₹ crore · consolidated · last 4 quartersNet profit₹ crore · consolidated · last 4 quarters
Quarter by quarter
Consolidated · ₹ crore| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|
| Q1 FY27Apr–Jun 2026 | 158.27 | — | 40.59 | — | 3.59 | 04 Aug 2026 |
|---|
| Q4 FY26Jan–Mar 2026 | 182.34 | — | 48.54 | — | 4.38 | 25 Jun 2026 |
|---|
| Q3 FY26Oct–Dec 2025 | 172.34 | — | 47.70 | — | 4.29 | 06 Feb 2026 |
|---|
| Q2 FY26Jul–Sep 2025 | 162.67 | — | 46.78 | — | 4.20 | 19 Dec 2025 |
|---|
Standalone results
Standalone · ₹ crore| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|
| Q1 FY27Apr–Jun 2026 | 105.68 | — | 33.83 | — | 3.00 | 04 Aug 2026 |
|---|
| Q4 FY26Jan–Mar 2026 | 80.17 | — | 25.77 | — | 2.31 | 25 Jun 2026 |
|---|
| Q3 FY26Oct–Dec 2025 | 90.28 | — | 26.87 | — | 2.42 | 06 Feb 2026 |
|---|
| Q2 FY26Jul–Sep 2025 | 87.88 | — | 29.74 | — | 2.67 | 19 Dec 2025 |
|---|
8 filings on record for this company.